Intra-Articular Injection of Triamcinolone Beneficial in Hip Osteoarthritis
FRIDAY, April 8, 2022 (HealthDay News) — For patients with hip osteoarthritis and at least moderate pain, an ultrasound-guided intra-articular hip injection of corticosteroid and local anesthetic, administered with advice and education, is effective …
Learn MoreACC: Lasting Reduction in BP Seen With Radiofrequency Renal Denervation
FRIDAY, April 8, 2022 (HealthDay News) — Radiofrequency renal denervation yields clinically meaningful and lasting blood pressure reductions up to 36 months, according to a study published online April 4 in The Lancet to coincide with the annual meeting of the American College of Cardiology, held from April 2 to 4 in Washington, D.C.
Felix Mahfoud, M.D., from Saarland University in Homburg, Germany, and colleagues conducted a randomized, single-blind, sham-controlled trial enrolling patients from 25 clinical centers with uncontrolled hypertension. Participants had 24-hour ambulatory systolic blood pressure between 140 mm Hg and
In the renal denervation group, the researchers observed significant reductions from baseline in mean ambulatory systolic and diastolic blood pressure, and these numbers were significantly lower than those in the sham control group at 24 and 36 months, despite a similar intensity of antihypertensive drug treatment. At 36 months, 77 and 93 percent of patients in the renal denervation and sham control groups, respectively, adhered to medication. The reduction in ambulatory systolic blood pressure at 36 months was −18.7 and −8.6 mm Hg for the renal denervation and sham control groups, respectively.
“Given this long-term safety and efficacy finding, renal denervation could provide an adjunctive treatment modality in the management of patients with hypertension,” the authors write.
Several authors disclosed financial ties to pharmaceutical and medical device companies, including Medtronic, which funded the study.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Learn MoreBenefits of Smoking Cessation Quantified in Patients With ASCVD
FRIDAY, April 8, 2022 (HealthDay News) — For patients with established atherosclerotic cardiovascular disease, the treatment benefit of smoking cessation is equivalent to the use of targeted pharmaceutical interventions in persistent smokers, accordi…
Learn MoreInsomnia Linked to Recurrent MACE in Coronary Heart Disease
FRIDAY, April 8, 2022 (HealthDay News) — For patients with coronary heart disease (CHD), insomnia is associated with an increased risk for recurrent major adverse cardiovascular events (MACE), according to a study presented at the annual congress of …
Learn MoreRecommendations Updated for Management of Heart Failure
FRIDAY, April 8, 2022 (HealthDay News) — In a clinical practice guideline issued by the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America and published online April 1 in the Journal of the Americ…
Learn MoreAmerican Academy of Dermatology, March 25 to 29
The annual meeting of the American Academy of Dermatology was held from March 25 to 29 in Boston and attracted more than 12,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested…
Learn MoreFrequent Insomnia Symptoms Can Cause Higher HbA1c
THURSDAY, April 7, 2022 (HealthDay News) — Multivariable regression (MVR) and one- (1SMR) and two-sample Mendelian randomization (2SMR) analyses indicate that frequent insomnia symptoms can cause higher hemoglobin A1c (HbA1c), according to a study pu…
Learn MoreSerum Sodium in Upper Part of Normal Range Linked to Heart Failure
THURSDAY, April 7, 2022 (HealthDay News) — Serum sodium in the upper part of normal range is associated with an increased risk for heart failure, according to a study published online March 29 in the European Heart Journal.Natalia I. Dmitrieva, Ph.D….
Learn MoreFDA Advisers Weigh COVID-19 Booster Shots for Fall
THURSDAY, April 7, 2022 (HealthDay News) — Outlining a daunting timeline for development of any updated COVID-19 vaccine for next fall, federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates w…
Learn MoreReport Says Nursing Home Industry Needs an Overhaul
THURSDAY, April 7, 2022 (HealthDay News) — The nursing home industry is awash in ineffective care and staffing shortages, claims a new report that calls for sweeping changes in an industry whose failures have only been exacerbated by the pandemic.Exp…
Learn More